[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100409069":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":12,"centralContacts":23,"locations":30,"responsibleParty":53,"collaborators":12,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":12,"enrollmentInfo":67,"targetDuration":12,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":79,"overallStatus":33,"whyStopped":12,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Hospital San Carlos, Madrid","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with negative diagnosis of SAHS","NO_INTERVENTION","Patients with low risk or negative diagnosis of SAHS will follow conventional management of their AF, according to the usual criteria of the Arrhythmia Unit",null,{"label":14,"type":6,"description":15,"interventionNames":16},"Patients with positive diagnosis of SAHS","Patients with intermediate or high risk of SAHS and positive diagnosis",[17],"Other: Treatment of SAHS",[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":12},"Treatment of SAHS","Patients diagnosed with SAHS will be treated in the Pneumology Service according to usual practice (dietary hygienic measures, CPAP, etc.).",[14],[24],{"name":25,"role":26,"phone":27,"phoneExt":28,"email":29},"Nicasio Pérez-Castellano, MD PhD","CONTACT","+34913303000","7278","nicasio.perez@salud.madrid.org",[31],{"facility":32,"status":33,"city":34,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Hospital Clínico San Carlos","RECRUITING","Madrid","28040","Spain","ES",{"type":39,"coordinates":40},"Point",[41,42],-3.70256,40.4165,{"lat":42,"lon":41},[45,48,51],{"name":46,"role":26,"phone":27,"phoneExt":28,"email":47},"Nicasio Pérez-Castellano, MDhPhD","dr.npc.clinical.trials@gmail.com",{"name":49,"role":50,"phone":12,"phoneExt":12,"email":12},"Norberto Torres-Esquivel, MD","SUB_INVESTIGATOR",{"name":52,"role":50,"phone":12,"phoneExt":12,"email":12},"María-Jesús García-Torrent, PhD",{"type":54,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Nicasio Perez Castellano","Principal Investigator","100409069","value-of-screening-and-treatment-of-sahs-in-the-management-of-af-ablation-candidates-100409069",false,"NCT04606693","Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates","Value of Screening and Treatment of Sleep Apnea-Hypopnea Syndrome in the Management of Atrial Fibrillation Ablation Candidates","SLEEP-AF","Inclusion Criteria:\n\n* Patients with paroxysmal or persistent atrial fibrillation\n* Recurrent atrial fibrillation despite treatment with at least one class I or III antiarrhythmic\n* No previous diagnosis of apnea-hypopnea syndrome\n\nExclusion Criteria:\n\n* Patients \\\u003C18 years\n* Pregnant women\n* Doubts about the patient's ability to perform a home respiratory polygraphy\n* Doubts about the patient's ability to acquire rhythm records with the Kardia system (smartphone required)\n* Unavailability for follow-up at our center for at least 1 year.","ALL","18 Years",{"count":68,"type":69},50,"ESTIMATED","INTERVENTIONAL",[72],"NA","The present prospective cohort study (not randomized) analyses the value of screening and treatment of SAHS in the management of patients with AF refractory to antiarrhythmics drugs, potentially candidates for ablation.\n\nPatients at low risk of suffering from SAHS will follow conventional management of their AF, according to the usual criteria of the Arrhythmia Unit. Patients with high or intermediate risk of SAHS, will undergo respiratory polygraphy. If the result is positive, they will be treated as standard for this syndrome and their heart rate will be monitored for 3 months. After this, the patient's arrhythmic load will be reevaluated differentiating patients into two groups, those that must be ablated from those that have improved their condition and the clinical criteria is no longer ablation but follow-up.",[75,76,77,78],"Atrial Fibrillation Paroxysmal","Atrial Fibrillation, Persistent","Apnea Syndrome","Hypopnea Syndrome",[80,81,82,83],"Atrial Fibrillation","Apnea","Hypopnea","SAHS","2025-09-09",{"date":86,"type":87},"2025-09-15","ACTUAL",{"date":89,"type":87},"2020-11-05",{"date":91,"type":69},"2026-12-31",{"name":5,"class":6},1]